- Filed
- Mar 10, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 26, 2026 | 89.62M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 86.59M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 84.4M sh |
| Shares Diluted restated | Q3 2026 · Jan 31, 2025 | 57.68M sh |
| Shares Diluted restated | Q3 2026 · Jan 31, 2025 | 57.66M sh |
| Capex | Q3 2026 · Jan 31, 2026 | $0 |
| Capex | Q3 2026 · Jan 31, 2025 | $67.87K |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | −$1.04M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −$770.28K |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $17.9K |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $336.25K |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | −$8.24M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | −$7.57M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | −$7.07M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | −$7.29M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | −$6.56M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | −$6.36M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | −$5.79M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | −$5.46M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $6.69M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $6.04M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $6.97M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $6.16M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $181.76K |
| Current Assets | Q3 2026 · Apr 30, 2025 | $478.23K |
| Total Assets | Q3 2026 · Jan 31, 2026 | $645.81K |
| Total Assets | Q3 2026 · Apr 30, 2025 | $786.48K |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.01 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.02 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | −$0.01 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | −$0.03 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $659.05K |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $1.82M |
| Sga Expense | Q3 2026 · Jan 31, 2025 | $478.91K |
| Sga Expense | Q3 2026 · Jan 31, 2025 | $1.38M |
| Net Income | Q3 2026 · Jan 31, 2026 | −$748.14K |
| Net Income | Q3 2026 · Jan 31, 2026 | −$2.02M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$580.71K |
| Net Income | Q3 2026 · Jul 31, 2025 | −$694.84K |
| Net Income | Q3 2026 · Jan 31, 2025 | −$409.33K |
| Net Income | Q3 2026 · Jan 31, 2025 | −$1.58M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$585.29K |
| Net Income | Q3 2026 · Jul 31, 2024 | −$586.71K |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$572.52K |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$1.49M |
| Operating Income | Q3 2026 · Jan 31, 2025 | −$298.63K |
| Operating Income | Q3 2026 · Jan 31, 2025 | −$1.28M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $321.43K |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $1.07M |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $345.91K |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $833.13K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $881.47K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $3.01M |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $885.86K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $2.8M |
| Revenue | Q3 2026 · Jan 31, 2026 | $1.2M |
| Revenue | Q3 2026 · Jan 31, 2026 | $4.07M |
| Revenue | Q3 2026 · Jan 31, 2025 | $1.23M |
| Revenue | Q3 2026 · Jan 31, 2025 | $3.63M |